Protagenic Therapeutics (PTIX) — Capital Reinvestment Ratio
Protagenic Therapeutics (PTIX) has a Capital Reinvestment Ratio of 0.11x as of September 2008, meaning it reinvests 0% of its operating cash flow ($6.90 Million) in capital expenditures ($765.00K). Check Protagenic Therapeutics tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Protagenic Therapeutics Capital Reinvestment Ratio (1999–2008)
This chart tracks Protagenic Therapeutics's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see PTIX operating cash flow.
Annual Capital Reinvestment Ratio for Protagenic Therapeutics (1999–2008)
Year-by-year Capital Reinvestment Ratio for Protagenic Therapeutics from 1999 to 2008. See free cash flow generation of Protagenic Therapeutics to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.47x | $4.36 Million | $2.03 Million | ▲ +463.3% |
| 2006 | 0.08x | $931.00K | $77.00K | ▼ -89.5% |
| 2003 | 0.79x | $1.87 Million | $1.48 Million | ▲ +4.1% |
| 2002 | 0.76x | $2.35 Million | $1.78 Million | ▼ -69.8% |
| 2001 | 2.52x | $1.50 Million | $3.79 Million | ▲ +173.6% |
| 2000 | 0.92x | $3.51 Million | $3.23 Million | ▲ +276.3% |
| 1999 | 0.24x | $331.00K | $81.00K | — |